Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Opsens Inc T.OPS

Healthcare Medical Devices
OpSens Inc. is a medical device cardiology-focused company. The Company offers an advanced optical-based pressure guidewire that aims at improving the clinical outcome of patients with coronary artery disease. The Company’s segments include Medical and Industrial. The Medical segment focuses on physiological measurements, such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR... see more

Recent & Breaking News (TSX:OPS)

OPSENS AWARDED INTERVENTIONAL SPECIALTY DIAGNOSTICS AGREEMENT WITH PREMIER FOR SAVVYWIRE(TM)

Canada NewsWire March 14, 2023

OPSENS ANNOUNCES SAVVYWIRE(TM) USED DURING TWO LIVE CASES AT CRT CONFERENCE

Canada NewsWire February 28, 2023

OpSens Reports Annual General and Special Shareholders Meeting Voting Results

Canada NewsWire January 25, 2023

OPSENS TO PARTICIPATE IN THE LYTHAM PARTNERS INVESTOR SELECT CONFERENCE

Canada NewsWire January 25, 2023

OPSENS ANNOUNCES RECORD FIRST QUARTER FISCAL 2023 FINANCIAL RESULTS

Canada NewsWire January 12, 2023

OPSENS TO HOST FIRST QUARTER FISCAL YEAR 2023 FINANCIAL RESULTS CONFERENCE CALL ON THURSDAY JANUARY 12, 2023

Canada NewsWire January 5, 2023

OPSENS ANNOUNCES FILING OF PRELIMINARY BASE SHELF PROSPECTUS

Canada NewsWire December 22, 2022

OPSENS ANNOUNCES CLOSING OF $11.5 MILLION BOUGHT DEAL PUBLIC OFFERING INCLUDING $1.5 MILLION OVER-ALLOTMENT OPTION EXERCISED IN FULL

Canada NewsWire December 22, 2022

OPSENS INC. ANNOUNCES $10 MILLION BOUGHT DEAL OFFERING

Canada NewsWire December 1, 2022

OPSENS ANNOUNCES FIRST SAVVYWIRE(TM) PROCEDURE IN NEW ZEALAND

Canada NewsWire November 29, 2022

OPSENS ANNOUNCES FOURTH QUARTER AND FISCAL YEAR 2022 FINANCIAL RESULTS

Canada NewsWire November 22, 2022

OPSENS TO HOST FOURTH QUARTER FISCAL YEAR 2022 FINANCIAL RESULTS CONFERENCE CALL AND YEAR-END UPDATE ON NOVEMBER 22, 2022

Canada NewsWire November 16, 2022

OPSENS ANNOUNCES DEPARTURE OF CFO

Canada NewsWire November 1, 2022

OpSens (TSX:OPS) announces first SavvyWire clinical cases in Europe

Trevor Abes  October 26, 2022

OPSENS ANNOUNCES FIRST SAVVYWIRE CLINICAL CASES IN EUROPE AND LAUNCH OF SAFE-TAVI STUDY

Canada NewsWire October 26, 2022

OpSens (TSX:OPS) announces first SavvyWire procedure in the U.S.

Trevor Abes  September 23, 2022

OPSENS ANNOUNCES FIRST SAVVYWIRE PROCEDURE IN THE UNITED STATES BY DR. PHILIPPE GENEREUX OF MORRISTOWN MEDICAL CENTER

Canada NewsWire September 23, 2022

OPSENS ANNOUNCES FDA CLEARANCE FOR THE SAVVYWIRE(TM) FOR USE IN TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) PROCEDURES

Canada NewsWire September 15, 2022

OpSens to Participate in the Transcatheter Cardiovascular Therapeutics Conference (TCT) in Boston September 16-19, 2022

Canada NewsWire September 14, 2022

OPSENS ANNOUNCES THIRD QUARTER FISCAL 2022 FINANCIAL RESULTS WITH RECORD QUARTERLY REVENUES

Canada NewsWire July 14, 2022